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EffectS of a multifaceted intervention on the Cardiovascular risk fAc-
tors in high risk hyPErtensive patients in primary prevention
(ESCAPE Trial)
Denis Pouchain, Dominique Huas, Jean-Pierre Lebeau, Franck Wilmart,
Vincent Renard, Pierre-Louis Druais
Collège National des Généralistes Enseignants, Recherche, Vincennes,
France
Aim: 
 
To show that a multifaceted intervention, aimed at general practitio-
ners (GP), can improve high risk hypertensive patients’ health outcomes,
without affecting their quality of life.
 
Method:
 
 Cluster randomized trial. The intervention consisted of one day of
medical education, aiming on the therapeutic targets and strategies for
achievement featured in the French guidelines, an electronic blood pressure
(BP) measurement device, a short leaflet summarizing the guidelines, 4 pre-
vention-dedicated consultations in 2 years, and a feedback on IG patients’
results at baseline and at 1 year follow-up.
Patient’s inclusion criteria: hypertensive patients with at least 2 other car-
diovascular risk factors in primary prevention.
Primary end point: number of patients achieving all the targets featured in
the guidelines. Secondary end points: number of patients achieving each
target, variation of the value of the targets, and quality of life (SF-8).
 
Results:
 
 128 GPs were randomized as clusters in the intervention group (IG),
and 131 in the control group (CG). GPs have included 1 832 hypertensive patients,
1 047 of them had type 2 diabetes. 1 823 patients were analyzed at 2 years.
The number of patients reaching all their targets increased by 3.54% in the
CG, and 6.57% in the IG (p < 0.02). The number of patients reaching their BP
targets increased by 3.7% in the CG, and by 13.8% in the IG (p < 0.01). Sys-
tolic BP decreased by 1.5 mmHg in the CG and by 6.3 mmHg in the IG (p <
0.001). Diastolic BP decreased by 1.4 mmHg in the CG and 3.5 mmHg in the
IG (p < 0.05). Change in quality of life was similar in the 2 groups.
 
Conclusion:
 
 A multifaceted intervention aimed at GPs improves high risk
hypertensive patients’ health outcomes without affecting their quality of life. 
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The prognostic value of the Ankle-Brachial Index to predict peri-ope-
rative mortality and cardiovascular events after major non-cardiovas-
cular surgery.
Victor Aboyans (1), Philippe Lacroix (1), Bertrand Combres (2), Johna-
than Hammel (1), Philippe Stierer (1), Nathalie Nathan-Denizot (2), Marc
Laskar (1)
(1) Hôpital Dupuytren, CHU Limoges, Service de CTCV & Angiologie,
Limoges, France - (2) Hôpital Dupuytren, CHU Limoges, Service d'Anes-
thésiologie, Limoges, France
Purpose:
 
 Patients with coronary artery disease (CAD) who undergo non-
cardiovascular surgery are at higher risk of peri-operative cardiovascular (CV)
events. While it is well known that patients with peripheral artery disease
(PAD) are overall at high risk of CV events, little is known about their peri-
operative prognosis in the setting of non-cardiovascular surgery (NCS). Com-
pared to the conventional risk assessment prior to major NCS, this study
assessed the incremental prognostic value of the ankle-brachial index (ABI), a
screening tool for PAD, to predict peri-operative prognosis.  
 
Methods:
 
 In 423 consecutive patients (age 69 ± 11 yrs), we estimated the
revised cardiac risk index (rCRI) and measured the ABI preoperatively. An
ABI <0.90 or >1.40 was considered abnormal. Patients were divided into 3
groups: those with clinical CVD (including clinical PAD), those with asymp-
tomatic PAD (no clinical CVD but abnormal ABI), and healthy subjects (no
clinical CVD, normal ABI). The composite primary outcome combined death,
non-fatal acute coronary syndrome, stroke or transient ischemic attack and
overt heart failure during the perioperative period. The secondary outcome
included similar events within the first month. Multivariate regression models
were used, adjusted for age, sex and conventional risk factors. 
 
Results:
 
 Eighty (19%) patients had clinical CVD. Subclinical PAD was
newly discovered in 53 (12.5%) cases. The primary outcome occured in 53
(12.5%) cases and the secondary outcome in 55 (13%) cases. Subclinical PAD
was an independent risk factor for the primary (Odds Ratio [OR]: 3.28; p=
0.008) and secondary outcomes (OR: 3.20; p= 0.009). Abnormal ABI was
associated with the primary (OR: 1.91; p=0.0499) and secondary outcomes
(OR: 1.99; p=0.034), independent of the rCRI.
 
Conclusion:
 
 The measurement of ABI before major non-cardiovascular
surgery is useful to detect those at high risk of peri-operative events, indepen-
dent of the conventional clinical risk assessment.
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Seasonal variation of heart rate variability in hypertensive patients 
 
Afef Ben Halima, Mehdi Ben Miled, Manel Ben Halima, Salem Kachboura
 
Abderrahmen Mami University Hospital, Cardiology, Ariana, Tunisie
 
Introduction:
 
 Epidemiologic data suggest that season changes could explain
the occurrence of cardiovascular complications particularly during winter. Auto-
nomic nervous system has been implicated in the increase of this risk. Heart rate
varibility (HRV)  is a non invasive tool exploring sympathic and parasympathic
systems.
 
Aim:
 
 The study of parameters of HRV during season changes in hyperten-
sive patients and to compare them to healthy subjects 
 
Methods: 
 
85 hypertensive patients underwent  24 holter recording during
one year;  from March 2006 to March  2007. The patients underwent record-
ings during the four seasons : spring, summer, autumn and winter. We studied
changes in HRV  in the temporal domain and the spectral domain during sea-
sonal changes. Seasonal variation of HRV were also studied in 40 healthy con-
trols and compared to those of hypertensive patients.  
 
Results: W
 
e noticed a decrease in the sympathic tone  in hypertensive patients
during warm and hot seasons(spring and summer)  and a relative increase in the
sympathic tone during cold seasons. There was also a trend toward an increase in
the sympathic tone during cold seasons in healthy subjects. There were no signif-
icant changes concerning HRV parameters exploring the parasympathic during the
whole year in hypertensive patients and healthy controls.  
 
Conclusion: 
 
There is a seasonal variation in autonomic nervous system
modulation. These variations are more accentuated in hypertensive patients
with an increase in the sympathic tone during cold seasons. These variations
could be deleterious on cardiovascular system and could explain the increases
in cardiovascular events during winter in hypertensive patients.
 
(Voir schémas page suivante)
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Respective contributions of traditional cardiovascular risk factors and
metabolic syndrome in the prediction of coronary heart disease
Vanina Bongard (1), Kouyate Vazoumana (2), Dorota Taraszkiewicz (3),
Michel Galinier (3), Didier Carrié (3), Jean-Bernard Ruidavets (4), Jean
Ferrières (3)
(1) CHU de Toulouse - Université de Toulouse, Département d'Epidémio-
logie - INSERM U558, Toulouse, France - (2) INSERM U558, Toulouse,
France - (3) CHU de Toulouse, Pôle Cardiovasculaire et Métabolique,
Toulouse, France - (4) CHU de Toulouse - INSERM U558, Département
d'Epidémiologie, Toulouse, France
Metabolic syndrome is associated with an increased risk of coronary heart
disease (CHD), but it is still debated whether it could act as an independent
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